http://www.richpharmaceuticals.com/wp-content/uploads/2013/09/pipeline1-e1396027308835.jpg This platform drug as shown promise for the treatment of Acute Myeloid Leukemia. Formally known as TPA, this platform small molecule has many potential therapeutic uses. Rich Pharmaceuticals is exploring multiple indications for the highest likelihood of commercialization success that has the potential to become new compelling treatments for patients.
Clinical program trial on phase 2 did u guys notice last month They were at phase 1 ...looks to like they r on right track and Then add to this http://www.canncodex.com/ I see major violent Move upward in the coming days....$$$$
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.